首页> 外文OA文献 >A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

【2h】

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

机译：一种新的CDK9抑制剂增加了诸如血液学恶性肿瘤多种模型中的venetoclax（abt-199）的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Darren C. Phillips; Sha Jin; Gareth P. Gregory; Qi Zhang; John Xue; Xiaoxian Zhao; Jun Chen; Yunsong Tong; Haichao Zhang; Morey Smith; Stephen K. Tahir; Rick F. Clark; Thomas D. Penning; Jennifer R. Devlin; Jake Shortt; Eric D. Hsi; Daniel H. Albert; Marina Konopleva; Ricky W. Johnstone; Joel D. Leverson; Andrew J. Souers;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies [J] . Darren C. Phillips, Sha Jin, Gareth P. Gregory, Leukemia . 2020,第6期

机译：一种新的CDK9抑制剂增加了诸如血液学恶性肿瘤多种模型中的venetoclax（abt-199）的功效
2. Combination of AZD4573, a Selective CDK9 Inhibitor, with Other Cell Death Inducing Agents Can Overcome De Novo Venetoclax Resistance in Preclinical Hematologic Tumor Models [J] . Cidado Justin, Boiko Scott, Proia Theresa, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：AZD4573，一种选择性CDK9抑制剂，具有其他细胞死亡诱导剂的组合可以在临床前血液肿瘤模型中克服Novo venetoclax抗性
3. A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models [J] . Yin Tinggui, Lallena Maria J., Kreklau Emiko L., Molecular cancer therapeutics . 2014,第6期

机译：新型CDK9抑制剂在临床血液肿瘤模型中显示出有效的抗肿瘤功效
4. Characterization of a Small Molecule IRAK4 Inhibitor for the Treatment of Inflammatory Disorders and Hematologic Malignancies [C] . Chrystelle Lamagna, Meagan Chan, Sothy Yi, International Molecular Medicine Tri-Conference. . 2016

机译：用于治疗炎症性疾病和血液性恶性肿瘤的小分子Irak4抑制剂的表征
5. Efficacy of a Mindfulness-Based Intervention in Reducing Burnout and Increasing Resilience in Registered Nurses Caring for Patients with Hematologic Malignancies [D] . Kopp, Erin Allyson. 2020

机译：基于令人思想的干预在减少倦怠和增加注册护士的恢复力的功效，为血液学恶性肿瘤的患者提供了增加
6. A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies [O] . Darren C. Phillips, Sha Jin, Gareth P. Gregory, -1

机译：新型CDK9抑制剂在多种血液系统恶性肿瘤模型中提高Venetoclax（ABT-199）的功效
7. IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies [O] . Dennis Kirchhoff, Beatrix Stelte-Ludwig, Hans-Georg Lerchen, 2020

机译：IL3ARA靶向抗体 - 药物共轭湾-943具有Kinesin主轴蛋白抑制剂有效载荷显示血液学恶性肿瘤临床前模型的疗效

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅